Skip to main content

Advertisement

Table 5 Univariate and multivariate Cox proportional hazard regression analysis for No-DM patients

From: Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study

Clinical outcomes (n, %) Univariate multivariate
HR (95% CI) P HR (95% CI) P
MACE 1.190 (0.976–1.451) 0.085 1.145 (0.937–1.401) 0.186
All-cause death 1.477 (0.827–2.637) 0.188 1.268 (0.686–2.344) 0.449
Cardiac death 0.886 (0.363–2.159) 0.790 0.772 (0.293–2.039) 0.602
Non-fatal MI 0.834 (0.493–1.413) 0.50 0.758 (0.441–1.304) 0.317
Stent thrombosis 0.692 (0.289–1.654) 0.407 0.573 (0.222–1.480) 0.250
Revascularization 1.188 (0.936–1.508) 0.157 1.184 (0.931–1.505) 0.168
TVR 1.619 (1.193–2.198) 0.002 1.539 (1.128–2.099) 0.007
TLR 2.109 (1.501–2.963) < 0.001 1.963 (1.390–2.772) < 0.001
Stroke 1.087 (0.611–1.932) 0.778 0.976 (0.538–1.771) 0.936
Bleeding 1.022 (0.798–1.310) 0.861 1.055 (0.807–1.379) 0.696
 BRAC 2_5 0.927 (0.625–1.374) 0.705 0.929 (0.625–1.381) 0.714
 BRAC 3_5 0.613 (0.213–1.766) 0.364 0.630 (0.216–1.839) 0.397
  1. DM diabetes mellitus, G2-DES second generation drug-eluting stent, BP-DES biodegradable polymer drug-eluting stent, MACE major adverse cardiac events, MI myocardial infarction, TVR target vessel revascularization, BARC Bleeding Academic Research Consortium definition